Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022
Anna Khoperia, Susan H Gawel, Jenna Bedrava, Nazibrola Chitadze, Maia Butsashvili, Alan Landay, Geoff A Beckett, Sophia Surguladze · 2026
Read Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022 by Anna Khoperia, Susan H Gawel, Jenna Bedrava, Nazibrola Chitadze, Maia Butsashvili, Alan Landay, Geoff A Beckett, Sophia Surguladze (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0347697.txt.
Description
Anna Khoperia and colleagues review seven years of liver cancer in Georgia, the Caucasus country that launched a national hepatitis C elimination program in 2015, in this 2026 PLOS ONE paper. Hepatitis C is a leading cause of hepatocellular carcinoma, so the team linked cancer, death, and treatment registries for cases diagnosed through 2022.
More than seventeen hundred cases appeared, mostly men around their early sixties, and two-thirds arrived at late stages; most patients had died by the end of follow-up. Screening of cancer patients for hepatitis C rose from rare to nearly universal, and over half of those tested carried the virus. The data show both the program's reach and how much cancer burden remains.
Catalog record
| CREATOR | Anna Khoperia, Susan H Gawel, Jenna Bedrava, Nazibrola Chitadze, Maia Butsashvili, Alan Landay, Geoff A Beckett, Sophia Surguladze |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32324 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |